-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
UNITED THERAPEUTICS Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2023.
- UNITED THERAPEUTICS Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 48.4M shares, a 2.62% decline year-over-year.
- UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 49.7M shares, a 2.47% increase from 2022.
- UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 48.5M shares, a 2.54% increase from 2021.
- UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 47.3M shares, a 6.05% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)